NVN Liquidation (NOVNQ) Competitors

Statera Biopharma (NASDAQ:STAB) and NVN Liquidation (NASDAQ:NOVNQ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, community ranking, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

Is STAB or NOVNQ more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Statera Biopharma	N/A	N/A	N/A
NVN Liquidation	N/A	N/A	N/A

Which has more volatility and risk, STAB or NOVNQ?

Statera Biopharma has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, NVN Liquidation has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500.

Does the MarketBeat Community favor STAB or NOVNQ?

Statera Biopharma and NVN Liquidation both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
Statera Biopharma	N/A	N/A
NVN Liquidation	N/A	N/A

Do analysts recommend STAB or NOVNQ?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Statera Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
NVN Liquidation	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has better earnings and valuation, STAB or NOVNQ?

NVN Liquidation has higher revenue and earnings than Statera Biopharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Statera Biopharma	$1.49M	0.03	-$101.85M	N/A	N/A
NVN Liquidation	$23.68M	0.00	-$31.31M	-$1.32	N/A

Does the media refer more to STAB or NOVNQ?

In the previous week, NVN Liquidation's average media sentiment score of 0.00 equaled Statera Biopharma'saverage media sentiment score.

Company	Overall Sentiment
Statera Biopharma	Neutral
NVN Liquidation	Neutral

Summary

NVN Liquidation beats Statera Biopharma on 3 of the 3 factors compared between the two stocks.